Approval for design changes to the distal fibers of the three hand-piece models. the device, as modified, will be marketed under the trade name tmr2000 holmium laser system and is indicated for trans-myocardial revascularization in patients with angina refractory to medical treatment and secondary to objectively demonstrated coronary artery atherosclerosis and with a region of the myocardium with reversible ischemia not amenable to direct coronary revascularization.